So-young Lee
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bioprocess Development of a Human Monoclonal Antibody against MERS-CoV: Analytical and Preclinical Studies.
Journal: Biomolecules & therapeutics
Published: January 02, 2026
Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus-2.
Journal: Journal of medical virology
Published: December 19, 2025
Long-term pulmonary sequelae and convalescent immune reactions in mild to moderate COVID-19 patients during the active treatment era.
Journal: PloS one
Published: March 13, 2025
A Novel Antibody Against the Non-Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein.
Journal: The Journal of infectious diseases
Published: October 24, 2024
Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity.
Journal: Journal of medical virology
Published: September 19, 2023
Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding.
Journal: Journal of Korean medical science
Published: September 13, 2022
The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections.
Journal: Scientific reports
Published: March 08, 2021
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
Journal: PloS one
Published: December 30, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026